According to Intellia Therapeutics's latest financial reports the company has a price-to-book ratio of 1.90.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.60 | 6.8% |
2022-12-31 | 2.43 | -71.22% |
2021-12-31 | 8.46 | 26.88% |
2020-12-31 | 6.67 | 144.33% |
2019-12-31 | 2.73 | 22.85% |
2018-12-31 | 2.22 | -17.94% |
2017-12-31 | 2.71 | 20.37% |
2016-12-31 | 2.25 | |
2015-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.43 | 27.89% | ๐บ๐ธ USA |